Daiwa Securities Group Inc. Bluebird Bio, Inc. Transaction History

Daiwa Securities Group Inc.

  • $18.8 Billion
  • Q2 2024

A detailed history of Daiwa Securities Group Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 333 shares of BLUE stock, worth $173. This represents 0.0% of its overall portfolio holdings.

Number of Shares
333
Previous 16,235 97.95%
Holding current value
$173
Previous $21,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$0.85 - $1.26 $13,516 - $20,036
-15,902 Reduced 97.95%
333 $0
Q1 2024

May 02, 2024
SELL
$0.91 - $1.75 $945 - $1,818
-1,039 Reduced 6.01%
16,235 $21,000
Q4 2023

Jan 31, 2024
SELL
$1.32 - $4.83 $7,669 - $28,062
-5,810 Reduced 25.17%
17,274 $24,000
Q2 2023

Jul 31, 2023
BUY
$2.79 - $5.03 $38,295 - $69,041
13,726 Added 146.68%
23,084 $76,000
Q1 2023

May 02, 2023
BUY
$3.14 - $8.22 $5,567 - $14,574
1,773 Added 23.38%
9,358 $30,000
Q4 2022

Feb 06, 2023
BUY
$5.77 - $8.49 $42,432 - $62,435
7,354 Added 3183.55%
7,585 $52,000
Q3 2022

Nov 02, 2022
SELL
$3.75 - $7.39 $83,385 - $164,324
-22,236 Reduced 98.97%
231 $1,000
Q2 2022

Aug 09, 2022
BUY
$2.94 - $5.23 $65,373 - $116,294
22,236 Added 9625.97%
22,467 $93,000
Q3 2021

Nov 05, 2021
BUY
$11.24 - $21.0 $1,191 - $2,226
106 Added 84.8%
231 $4,000
Q4 2020

Feb 04, 2021
SELL
$27.5 - $37.92 $6,655 - $9,176
-242 Reduced 65.94%
125 $5,000
Q3 2020

Nov 02, 2020
BUY
$34.44 - $43.75 $1,894 - $2,406
55 Added 17.63%
367 $20,000
Q4 2019

Jan 31, 2020
SELL
$46.96 - $61.67 $1,737 - $2,281
-37 Reduced 10.6%
312 $27,000
Q2 2019

Jul 24, 2019
SELL
$75.84 - $105.21 $293,955 - $407,793
-3,876 Reduced 91.74%
349 $44,000
Q1 2019

Apr 26, 2019
SELL
$64.44 - $104.11 $128,815 - $208,115
-1,999 Reduced 32.12%
4,225 $665,000
Q4 2018

Feb 05, 2019
SELL
$59.1 - $93.26 $546,143 - $861,815
-9,241 Reduced 59.75%
6,224 $617,000
Q3 2018

Nov 01, 2018
SELL
$88.86 - $117.49 $4,443 - $5,874
-50 Reduced 0.32%
15,465 $2.26 Million
Q2 2018

Jul 30, 2018
BUY
$99.64 - $127.59 $429,049 - $549,402
4,306 Added 38.42%
15,515 $2.44 Million
Q1 2018

May 02, 2018
BUY
$105.8 - $150.94 $80,937 - $115,469
765 Added 7.32%
11,209 $1.91 Million
Q4 2017

Feb 06, 2018
SELL
$81.25 - $130.7 $879,043 - $1.41 Million
-10,819 Reduced 50.88%
10,444 $1.86 Million
Q3 2017

Nov 02, 2017
BUY
$57.74 - $91.42 $1.23 Million - $1.94 Million
21,263
21,263 $2.92 Million

Others Institutions Holding BLUE

# of Institutions
162
Shares Held
79.9M
Call Options Held
525K
Put Options Held
634K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $40.1M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email